Bio-Techne TECH US — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's us — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's US — revenue?
- Bio-Techne (TECH) reported US — revenue of $167.48M in Q1 2026.
- How has Bio-Techne's US — revenue changed year-over-year?
- Bio-Techne's US — revenue decreased by 7.9% year-over-year, from $181.92M to $167.48M.
- What is the long-term trend for Bio-Techne's US — revenue?
- Over 4 years (2021 to 2025), Bio-Techne's US — revenue has grown at a 8.0% compound annual growth rate (CAGR), from $502.08M to $683.23M.
- What does US — revenue mean?
- The total net revenue earned from customers in the United States, excluding collected sales taxes.
- How do you interpret US — revenue?
- An increase indicates growing market share or higher demand for products in the domestic market, while a decrease may signal competitive pressure or economic headwinds.
- How does US — revenue compare across companies?
- Comparable to domestic net revenue or regional segment sales reported by other life sciences and diagnostic equipment manufacturers.